Know Labs (NYSE:KNW) announced that it entered into a series of strategic partnerships as it looks to move toward a major regulatory nod.
Seattle-based Know Labs develops the Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. This technology integrates into wearable, mobile or bench-top form factors. Know Labs developed the first application of Bio-RFID as a non-invasive glucose monitor.
The company said in a news release that its new partnerships collectively accelerate progress toward FDA clearance for the monitor. These partnerships include leading experts in data science, sensor technology, product design and regulatory affairs.
New CEO Ron Erickson — appointed last week — cited a need for both time and “thoughtful attention to detail” as part of the decision to bring on these industry experts.
“We are fortunate to have world-class respected experts working alongside our own talented Know Labs team, to help accelerate our progress on data science, product design and the regulatory process, as we develop medical devices that we believe will transform patient care,” Erickson said.
About the new partnerships for Know Labs
Know Labs chose Dr. Reza Kassayan to assist in refining its Bio-RFID sensor. A 30-year veteran of the industry, Kassayan previously served as lead designer and system architect for a number of large-scale products. He specializes in ultra-miniaturized, embedded electronics for medical devices.
“It’s inspiring to see the potential impact for this novel application of radio frequency spectroscopy,” Kassayan said. “Having engineered other life-changing non-invasive medical devices, I’m thrilled to be supporting this development.”
The company also partnered with Igor Institute, a product development firm specializing in mechanical, electrical and firmware engineering. Igor Institute and Know Labs’ relationship dates back to 2018.
Bould Design, an industrial firm behind products like Nest, Roku and Willow, provides design support.
Edge Impulse, a development toolkit for machine learning, works with the company to refine its Bio-RFID algorithm. The two companies began working together six months ago to accelerate algorithm development.
Know Labs also partnered with medical device consulting firm Novus Management Group. Novus provides regulatory systems and strategy guidance to prepare the company for the FDA clearance process.
Finally — as previously announced — the company enlisted Racer Technology to manufacture its KnowU and UBand devices. The medical device contract manufacturer previously supported FDA-approved devices from companies such as Medtronic, Boston Scientific and Bio-Rad.